CCIL Program Leader Elected AAAS Fellow

CCIL Program Leader Elected AAAS Fellow

Paul HergenrotherPaul Hergenrother, professor of chemistry and leader of the CCIL Program 2 (Cancer Discovery Platforms Bridging the Engineering-Biology Continuum), is one of eight Illinois faculty members elected as a 2019 Fellow of the American Association for the...

PAC-1 Trial in Humans with Brain Cancer Extended

PAC-1 Trial in Humans with Brain Cancer Extended

Timothy Fan and Paul HergenrotherA drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the...